Pfizer (NYSE:PFE)

Short Sellers Back Way Off Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

During the presidential campaign of 2015–2016, one of the areas that got some of the largest scrutiny was drug pricing, and with good reason. Spending on pharmaceuticals when the population ...
Read Full Story »

Pfizer Earnings Not Enough for Investors

When Pfizer Inc. (NYSE: PFE) released its third-quarter earnings report before the markets opened on Tuesday, the results and guidance lived up to what analysts expected but weren't enough to ...
Read Full Story »

What to Expect When Pfizer Reports Earnings

Pfizer Inc. (NYSE: PFE) is scheduled to release its third-quarter financial results before the markets open on Tuesday. The consensus estimates from Thomson Reuters are $0.65 in earnings per share ...
Read Full Story »

Facebook, Alibaba and More Major Earnings to Look For This Week

Over the course of the past week, markets were largely driven higher as the result of some amazing Dow earnings, not to mention an onslaught of tech earnings last Thursday. ...
Read Full Story »

Top Biopharma Events Coming by the End of 2017

As the markets continue to hit all-time highs, biotech and pharmaceutical companies have been part of these massive gains. There is a very positive sentiment in the health care sector ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 6 Most Shorted NYSE Stocks

The beginning of October not only ushered in the fourth quarter, but a time of the year when the markets can be volatile. The bull run approached nine years long, ...
Read Full Story »

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

The bull market is now closer to nine years old than it is eight, and the great stock market rally of 2017 has continued to amaze skeptics and bulls alike. ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Short Interest Piles On

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech company, it would be in a successful treatment of Alzheimer's ...
Read Full Story »

McDonald’s Lifts, Apple Weighs on DJIA Wednesday

September 20, 2017: Markets opened narrowly mixed Wednesday as traders awaited the FOMC's afternoon announcement. Though short on details, the Fed will begin normalizing its balance sheet next month. Consumer ...
Read Full Story »

United Technologies, Pfizer Lead DJIA Higher on Thursday

September 14, 2017: Markets opened lower Thursday but the blue chip DJIA turned north quickly and traded in the green (and touched a new intra-day high) for the rest of ...
Read Full Story »

Why Pfizer Is Pushing the Dow to All-Time Highs

Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on the day. In fact, Pfizer Inc. (NYSE: PFE), Merck & ...
Read Full Story »